Gleamer
Latest round
- Series B
Last raised
- Jun 2023
Total raised
- $38M
Investors
- 9
About Gleamer
Gleamer Sas was founded in 2017 in France, focusing on developing AI-driven solutions for medical imaging. The company has undergone no notable pivots in its business strategy. Its founders are Alexis Ducarouge, Christian Allouche, Katie Ford, and Nor-eddine Regnard, with Christian Allouche currently serving as the CEO. In March 2026, RadNet Management, Inc.Elaia Partners, XAnge, Bpifrance Investissement Régions, Kima Ventures, MACSF, Crista Galli Ventures, Majycc eSante Invest, UI Investissement, Supernova Invest, Heal Capital, and Government of France.Gleamer specializes in innovative artificial intelligence solutions designed to enhance radiology workflows and improve diagnostic accuracy. Their flagship products include Gleamer BoneView, which establishes a new standard in bone trauma interpretation, and Gleamer ChestView, aimed at enhancing the detection of urgent and cancerous findings in chest imaging. Additionally, Gleamer offers BoneMetrics for automated musculoskeletal measurements, BoneAge for precise age assessments beyond traditional atlases, and BreastView, a precision AI tool for early breast cancer detection. These products are primarily utilized by healthcare institutions across various countries, supporting medical professionals in over 45 nations, with a client base encompassing more than 2,000 health institutions and facilitating approximately 35 million patient exams annually.Gleamer's revenue model is primarily built on B2B transactions, where the company partners with healthcare institutions to integrate its AI solutions into existing radiology systems. The firm operates through a subscription-based model, allowing clients to access and utilize their products over specified periods, which may include licensing fees for each institution or exam conducted. Each product, such as Gleamer BoneView and BreastView, is tailored to address specific clinical needs. The structure of these partnerships typically involves direct contracts with hospitals and medical facilities, ensuring that services are delivered consistently and effectively. Given the scalability of AI solutions in medical imaging, Gleamer's offerings are designed to streamline workflows and improve patient care, fostering long-term relationships with healthcare providers. The acquisition aims to expand artificial intelligence capabilities in medical imaging and address rising imaging demand amid a shortage of radiologists.
Who invested in Gleamer
9 investors across 2 rounds
See all investors in Gleamer
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Gleamer
Who invested in Gleamer?
Gleamer has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gleamer raised?
Gleamer has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Gleamer last raise money?
Gleamer's most recent round on record is a Series B, in Jun 2023.
What does Gleamer do?
Gleamer Sas was founded in 2017 in France, focusing on developing AI-driven solutions for medical imaging.
Where is Gleamer headquartered?
Gleamer is headquartered in France.
Which VCs invest in companies like Gleamer?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at Gleamer's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Gleamer? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.